Alert: Major Price Decline (8/27/24)-Lifecore Biomedical Inc (NASDAQ: LFCR).

out_logo_500#25222.jpg

Lifecore Biomedical Inc (NASDAQ: LFCR) stock closed at $4.74 on 8/27/24 after a major decline of -25.2%. Moreover, trading volume in this decline was exceptionally high at 827% of normal. The stock has declined -15.4% during the last week and has been extremely weak relative to the market over the last nine months.

out_mm#25222.jpg

Current PriceTarget Research Rating

LFCR’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.

Lifecore Biomedical is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.


*